Bacteriostatic and bactericidal activity of levofloxacin against clinical isolates from cystic fibrosis patients

被引：0
作者：
G. Golini
F. Favari
F. Marchetti
R. Fontana
机构：
[1] University of Verona,Department of Pathology, Microbiology Section
[2] Ospedale Civile Maggiore,Clinical Microbiology Laboratories
[3] GlaxoSmithKline Spa,Medical Department, Antibacterials Division
来源：
European Journal of Clinical Microbiology and Infectious Diseases | 2004年 / 23卷
关键词：
Cystic Fibrosis; Fluoroquinolones; Levofloxacin; Ceftazidime; Tobramycin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：798 / 800
页数：2
相关论文
共 31 条
  • [1] Gilligan PH(1991)Microbiology of airway disease in patients with cystic fibrosis Clin Microbiol Rev 4 35-51
  • [2] Govan JRW(1996)Microbial pathogenesis in cystic fibrosis: mucoid Microbiol Rev 60 539-574
  • [3] Deretic V(2002) and Drugs 62 2127-2167
  • [4] Hurst M(2003)Levofloxacin. A review on its clinical use J Chemother 15 315-322
  • [5] Lamb HM(1999)Current and future perspectives of levofloxacin in the treatment of severe Antimicrob Agents Chemother 43 428-431
  • [6] Scott LJ(2003) infections J Chemother 15 118-124
  • [7] Figgitt DP(2000)Italian survey on the comparative levofloxacin susceptibility in 334 clinical isolates of Int J Antimicrob Agents Chemother 13 223-226
  • [8] Marchetti F(1998)Comparative bactericidal activity of fluoroquinolones against clinical isolates resistant to fluoroquinolones Pharmacodynamics of levofloxacin a-1122
  • [9] Viale P(2001)Bactericidal activity of levofloxacin and ciprofloxacin on different phenotypes of Chest 119 1114-undefined
  • [10] Segatore B(undefined) clinical isolates undefined undefined undefined-undefined
1234